Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure

European Heart Journal

Volumn 25, Issue 20, 2004, Pages 1788-1796

  Gackowski, Andrzej ^a,b   Isnard, Richard ^a   Golmard, Jean Louis ^a   Pousset, Franca̧oise ^a   Carayon, Alain ^a   Montalescot, Gilles ^a   Hulot, Jean Sébastien ^a   Thomas, Daniel ^a   Piwowarska, Wieslawa ^b   Komajda, Michel ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

Author keywords

Acute heart failure; B type natriuretic peptide; Echocardiography; Prognosis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; BIOLOGICAL MONITORING; CLINICAL EXAMINATION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DOPPLER ECHOCARDIOGRAPHY; EVALUATION; FEMALE; FOLLOW UP; HEALTH STATUS; HEART ARREST; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RESUSCITATION; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; POINT-OF-CARE SYSTEMS; RISK FACTORS;

EID: 4944251065     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.07.038     Document Type: Article

References (32)

1. F. Zannad, S. Briancon, and Y. Juilliere Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study J Am Coll Cardiol 33 1999 734 742
2. E.F. Philbin, and T.G. DiSalvo Prediction of hospital readmission for heart failure: development of a simple risk score based on administrative data J Am Coll Cardiol 33 1999 1560 1566
3. P.J. Cowburn, J.G. Cleland, and A.J. Coats Risk stratification in chronic heart failure Eur Heart J 19 1998 696 710
4. P.A. McCullough, E.F. Philbin, and J.A. Spertus Confirmation of heart failure epidemic: findings from the resource utilization among congestive heart failure (REACH) study J Am Coll Cardiol 39 2002 60 69
5. Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-60
6. J.D. Sandham, R.D. Hull, and R.F. Brant A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients N Engl J Med 2 2003 5 14
7. B.C. Stein, and R.I. Levin Natriuretic peptides: physiology, therapeutic potential and risk stratification in ischemic heart disease Am Heart J 135 1998 914 923
8. B.M.Y. Cheung, and C.R. Kumana Natriuretic peptides â€" relevance in cardiac disease JAMA 280 1998 1983 1984
9. N. Hama, H. Itoh, and G. Shirakami Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction Circulation 92 1995 1558 1564
10. M. Yoshimura, H. Yasue, and K. Okamura Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure Circulation 87 1993 464 469
11. K. Maeda, T. Tsutamoto, and A. Wada Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction Am Heart J 135 1998 825 832
12. R. Kazanegra, V. Cheng, and A. Garcia A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study J Card Fail 7 2001 21 29
13. M.R. Cowie BNP: soon to become a routine measure in the care of patients with heart failure Heart 83 2000 617 618
14. T.A. McDonagh, S.D. Robb, and D.R. Murdoch Biochemical detection of left-ventricular systolic dysfunction Lancet 351 1998 9 13
15. A.S. Maisel, J. Koon, and P. Krishnaswamy Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction Am Heart J 141 2001 367 374
16. E. Lubien, A. DeMaria, and P. Krishnaswamy Utility of B-natriuretic peptide in detecting diastolic dysfunction. Comparison with doppler velocity recordings Circulation 105 2002 595 601
17. M.R. Cowie, A.D. Struthers, and D.A. Wood Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care Lancet 350 1997 1349 1352
18. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Breathing Not Properly Multinational Study Investigators.Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
19. P.A. McCullough, R.M. Nowak, and J. McCord B-type natriuretic peptide and clinical judgement in emergency diagnosis of heart failure. analysis from breathing not properly (BNP) multinational study Circulation 106 2002 416 422
20. D. Logeart, C. Saudubray, and P. Beyne Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea J Am Coll Cardiol 40 2002 1794 1800
21. D.R. Murdoch, T.A. McDonagh, and J. Byrne Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy Am Heart J 138 1999 1126 1132
22. R.W. Troughton, C.M. Frampton, and T.G. Yandle Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Lancet 355 2000 1126 1130
23. T. Omland, A. Aakvaag, and V.V. Bonarjee Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide Circulation 93 1996 1963 1969
24. J. Koglin, S. Pehlivanli, and M. Schwaiblmair Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure J Am Coll Cardiol 38 2001 1934 1941
25. R. Isnard, F. Pousset, and O. Chafirovskaia Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure Am Heart J 146 2003 729 735
26. R.S. Gardner, F. Ozalp, and A.J. Murday N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure Eur Heart J 24 2003 1735 1743
27. P. Bettencourt, F. Frioes, and A. Azevedo Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure Int J Cardiol 93 2004 45 48
28. C.M. Yu, and J.E. Sanderson Plasma brain natriuretic peptide â€" an independent predictor of cardiovascular mortality in acute heart failure Eur J Heart Fail 1 1999 59 65
29. D. Logeart, G. Thabut, and P. Jourdain Pre-discharge B-type natriuretic peptide assay for identifying patients at high risk of readmission after decompensated heart failure J Am Coll Cardiol 2004
30. W. Johnson, T. Omland, and C. Hall Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure J Am Coll Cardiol 39 2002 1623 1629
31. K.K. Ho, J.L. Pinsky, and W.B. Kannel The epidemiology of heart failure: the Framingham study J Am Coll Cardiol 22 1993 6A 13A
32. V. Cheng, R. Kazanagra, and A. Garcia A rapid bedside test for B-type natriuretic peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study J Am Coll Cardiol 37 2001 386 391